However, among all genes associated with LUAD prognosis, only CDK1 was differentially expressed in tumor and normal lung tissues (Figure 1E), indicating that CDK1 might be a valuable biomarker for prognostic prediction and targeted therapy in LUAD. This evidence concerns the gene CDK1 and neoplasm.